Endpoint Determination

"Endpoint Determination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Establishment of the level of a quantifiable effect indicative of a biologic process. The evaluation is frequently to detect the degree of toxic or therapeutic effect.

Descriptor ID	D023381
MeSH Number(s)	E05.315
Concept/Terms	Endpoint Determination Endpoint Determination Determination, Endpoint Determinations, Endpoint Endpoint Determinations End Point Determination Determinations, End Point End Point Determinations Point Determinations, End Endpoint Assay Endpoint Assay Assay, Endpoint Assays, Endpoint Endpoint Assays End Point Assay Assay, End Point Assays, End Point End Point Assays Point Assay, End Point Assays, End

Below are MeSH descriptors whose meaning is more general than "Endpoint Determination".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Investigative Techniques [E05]
Endpoint Determination [E05.315]

Below are MeSH descriptors whose meaning is related to "Endpoint Determination".

Below are MeSH descriptors whose meaning is more specific than "Endpoint Determination".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Endpoint Determination" by people in this website by year, and whether "Endpoint Determination" was a major or minor topic of these publications.

Bar chart showing 18 publications over 11 distinct years, with a maximum of 4 publications in 2014

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2001	0	1	1
2009	0	1	1
2011	0	1	1
2012	1	2	3
2013	2	1	3
2014	1	3	4
2016	0	1	1
2019	1	0	1
2020	1	0	1
2023	0	1	1
2024	1	0	1

Below are the most recent publications written about "Endpoint Determination" by people in Profiles.

Aimo A, Olivotto I, Todiere G, Barison A, Panichella G, Fiuzat M, Linde C, Lakdawala NK, Desai M, Zannad F, Maron MS. Endpoint Selection in Randomized Clinical Trials for Hypertrophic Cardiomyopathy. JACC Heart Fail. 2025 Feb; 13(2):200-212.

View in: PubMed
Haque R, Watson CM, Liu J, Carter EK, Duong DM, Lah JJ, Wingo AP, Roberts BR, Johnson ECB, Saykin AJ, Shaw LM, Seyfried NT, Wingo TS, Levey AI. A protein panel in cerebrospinal fluid for diagnostic and predictive assessment of Alzheimer's disease. Sci Transl Med. 2023 09 06; 15(712):eadg4122.

View in: PubMed
Martins PN, Rizzari MD, Ghinolfi D, Jochmans I, Attia M, Jalan R, Friend PJ. Design, Analysis, and Pitfalls of Clinical Trials Using Ex Situ Liver Machine Perfusion: The International Liver Transplantation Society Consensus Guidelines. Transplantation. 2021 04 01; 105(4):796-815.

View in: PubMed
Hedlin H, Garcia A, Weng Y, He Z, Sundaram V, Bunning B, Balasubramanian V, Cunanan K, Kapphahn K, Gummidipundi S, Purington N, Boulos M, Desai M. Clinical trials in a COVID-19 pandemic: Shared infrastructure for continuous learning in a rapidly changing landscape. Clin Trials. 2021 06; 18(3):324-334.

View in: PubMed
Rabe KF, Halpin DMG, Han MK, Miravitlles M, Singh D, Gr?nke L, Vo? F, Martinez FJ. Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial. Respir Res. 2020 Jul 09; 21(1):177.

View in: PubMed
Dong G, Huang B, Chang YW, Seifu Y, Song J, Hoaglin DC. The win ratio: Impact of censoring and follow-up time and use with nonproportional hazards. Pharm Stat. 2020 05; 19(3):168-177.

View in: PubMed
Ward DS, Williams MR, Berkenbosch JW, Bhatt M, Carlson D, Chappell P, Clark RM, Constant I, Conway A, Cravero J, Dahan A, Dexter F, Dionne R, Dworkin RH, Gan TJ, Gozal D, Green S, Irwin MG, Karan S, Kochman M, Lerman J, Lightdale JR, Litman RS, Mason KP, Miner J, O'Connor RE, Pandharipande P, Riker RR, Roback MG, Sessler DI, Sexton A, Tobin JR, Turk DC, Twersky RS, Urman RD, Weiss M, Wunsch H, Zhao-Wong A. Evaluating Patient-Centered Outcomes in Clinical Trials of Procedural Sedation, Part 2 Safety: Sedation Consortium on Endpoints and Procedures for Treatment, Education, and Research Recommendations. Anesth Analg. 2018 11; 127(5):1146-1154.

View in: PubMed
Williams MR, Ward DS, Carlson D, Cravero J, Dexter F, Lightdale JR, Mason KP, Miner J, Vargo JJ, Berkenbosch JW, Clark RM, Constant I, Dionne R, Dworkin RH, Gozal D, Grayzel D, Irwin MG, Lerman J, O'Connor RE, Pandharipande P, Rappaport BA, Riker RR, Tobin JR, Turk DC, Twersky RS, Sessler DI. Evaluating Patient-Centered Outcomes in Clinical Trials of Procedural Sedation, Part 1 Efficacy: Sedation Consortium on Endpoints and Procedures for Treatment, Education, and Research Recommendations. Anesth Analg. 2017 03; 124(3):821-830.

View in: PubMed
Crabb DW, Bataller R, Chalasani NP, Kamath PS, Lucey M, Mathurin P, McClain C, McCullough A, Mitchell MC, Morgan TR, Nagy L, Radaeva S, Sanyal A, Shah V, Szabo G. Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia. Gastroenterology. 2016 Apr; 150(4):785-90.

View in: PubMed
Pappas DA, Kremer JM, Reed G, Greenberg JD, Curtis JR. "Design characteristics of the CORRONA CERTAIN study: a comparative effectiveness study of biologic agents for rheumatoid arthritis patients". BMC Musculoskelet Disord. 2014 Apr 01; 15:113.

View in: PubMed

People

Explore

Similar Concepts

Top Journals